Who is sponsoring NCT05015088?

NCT05015088 is sponsored by Regis University.

What drugs are being tested in NCT05015088?

Interventions in NCT05015088: No interventions will be performed in this study.

What condition does NCT05015088 study?

NCT05015088 studies Gastrocnemius Tightness.

Is NCT05015088 still recruiting?

NCT05015088 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT05015088: Gastroc

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Gastrocnemius Stretching

Completed Last updated 10 October 2023

What this trial tests

trial testing No interventions will be performed in this study in Gastrocnemius Tightness in 20 participants. Completed in 15 April 2023.

Timeline

1 May 2022

Primary endpoint
1 April 2023

15 April 2023

Quick facts

Lead sponsor	Regis University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 May 2022
Primary completion	1 April 2023
Estimated completion	15 April 2023
Sites	1 location across United States

Drugs / interventions tested

No interventions will be performed in this study

Conditions studied

Gastrocnemius Tightness — all drugs for Gastrocnemius Tightness →

Sponsor

Regis University

Who can join

Adults 18 to 65, any sex, with Gastrocnemius Tightness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to: (1) determine muscle activation of the tibialis posterior muscle during different common gastrocnemius stretches and (2) radiographically quantify the tibial-calcaneal angle during the common stretching positions. We hypothesize that stretching over the edge of a step with the arch supported will minimize the activation of the tibialis posterior muscle in addition to increasing the tibial-calcaneal angle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Regis University trials

Trials by the same sponsor.

NCT04487327 — The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional Outcomes in Individuals With Inju · NA · completed
NCT03689283 — The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Trigger Points · NA · completed
NCT04223245 — A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease · NA · completed
NCT04040218 — Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient · NA · completed
NCT04164303 — Conservative Management of DeQuervain's Tendinopathy With an Orthopaedic Manual Therapy Approach Emphasizing First CMC M · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05015088 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Regis University
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05015088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing